Lorcaserin and Q-Nexa Before FDA

  • Share
    Share Video

  • Add
  • More
    Report this video as:
0 0
You have already voted for this video.
Dr. David Samadi, leading prostate cancer surgeon, says the FDA could approved these two new weight loss dr...
Dr. David Samadi, leading prostate cancer surgeon, says the FDA could approved these two new weight loss drugs as early as June 2012. While heart valve damage is a potential side effect, the benefits of weight loss could outweigh the risks for some patients. Neither drug promises significant weight loss, however, and are not a substitute for portion control, health diet, and exercise. *******www.roboticoncology****
Categories:
Related